Attovia Therapeutics Inc. (ATTO)
NYSE
Closed
Oct 7, 2026
Day's Range
16.3352 wk Range
16.15Overview - ATTO - Attovia Therapeutics Inc.
Key Statistics
Valuation
Enterprise Value
931.25M
P/E (Trailing)
‪-7.23‬
P/E (Forward)
‪-7.21‬
PEG Ratio
‪0.01‬
Price / Sales (TTM)
‪435.46‬
Price / Book
‪-5.07‬
EV / EBITDA
‪-12.37‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪-4,845.11%‬
Return on Assets
‪-36.70%‬
Return on Equity
‪56.68%‬
Ownership
Shares Outstanding
43.02M
Float
26.26M
Held by Insiders
‪8.85%‬
Held by Institutions
‪42.56%‬
Price stats
50-Day Avg
‪20.88‬
200-Day Avg
‪20.88‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
5 analysts
Market Cap - ATTO - Attovia Therapeutics Inc.
Peers - ATTO - Attovia Therapeutics Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NYSE.
- ATTONYSEAttovia Therapeutics Inc.783.83MMarket Cap-27.55%52-week change-7.23P/E (Trailing)‪0.00%‬Profit Margin
- BIONYSEBio-Rad Laboratories Inc.9.87BMarket Cap+16.25%52-week change44.96P/E (Trailing)‪8.58%‬Profit Margin
- BHVNNYSEBiohaven Ltd.1.94BMarket Cap-23.39%52-week change-1.88P/E (Trailing)‪0.00%‬Profit Margin
- BSTNYSEBlackRock Science and Technology Trust1.76BMarket Cap+21.83%52-week change7.02P/E (Trailing)‪0.00%‬Profit Margin
- BCXNYSEBlackRock Resources & Commodities Strategy Trust991.85MMarket Cap+22.29%52-week change4.66P/E (Trailing)‪0.00%‬Profit Margin
- ANRONYSEAlto Neuroscience Inc.973.20MMarket Cap+73.63%52-week change-11.34P/E (Trailing)‪0.00%‬Profit Margin
- ARMPNYSEArmata Pharmaceuticals, Inc.130.88MMarket Cap+9.09%52-week change-0.73P/E (Trailing)‪0.00%‬Profit Margin
Profile Summary - ATTO - Attovia Therapeutics Inc.
About
Attovia Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing precision biologics for immune-mediated diseases. The company’s core work centers on its ATTOBODY platform, which is designed to create multispecific protein therapies that target multiple disease pathways involved in…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
